ANIMAL LENTIVIRUSES--STRATEGIES FOR HIV VACCINATION
ANIMAL LENTIVIRUSES--STRATEGIES FOR HIV VACCINATION
批准号:
3069192
负责人:
DAVID L HUSO
金额:
$7.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 1997-09-29
关键词:
Baculoviridae Retroviridae active immunization epitope mapping fusion gene gene mutation genetic manipulation genetic mapping glycoprotein structure glycoproteins goats human immunodeficiency virus immunogenetics laboratory rabbit neutralizing antibody nucleic acid sequence oligonucleotides polymerase chain reaction protein purification sheep transfection /expression vector virus envelope virus protein
中文摘要
人类免疫缺陷病毒(HIV)是慢病毒的成员
亚家族,一组非致癌逆转录病毒,
持续感染宿主免疫系统的细胞。 这些是
具有高度糖基化包膜糖蛋白的包膜病毒
(env gp),其在受感染的宿主中刺激强烈的免疫应答。
然而,在自然感染过程中引起的免疫应答不能
控制病毒复制,导致持续感染,
最终导致慢性多系统疾病和死亡。 许多
介导细胞嗜性、细胞病变性和
抗体对病毒的中和作用已被映射到Env GP上
艾滋病。 然而,慢病毒包膜的特性,
对无效的抗慢病毒免疫应答了解甚少,
很难用艾滋病毒本身进行评估。 对这些领域的见解是
这对于制定有效的基于免疫的艾滋病毒战略至关重要。
山羊关节炎脑炎病毒(CAEV)和绵羊维斯纳病毒(Visna virus)
绵羊是两种密切相关的、特征良好的慢病毒,
它们在许多生物学和结构特征上反映了艾滋病毒。
CAEV和visna的感染性分子克隆,
完全测序可供研究,并提供了一个系统,
它解决了慢病毒免疫原性和发病机制的问题,
在自然宿主中 该提案侧重于绘图,
表征绵羊/山羊慢病毒的功能结构域
埃纳湾 将构建一组截短和突变的env gp基因
使用聚合酶链式反应,
引物并亚克隆到杆状病毒表达载体中。
表达各种形式的env gp的重组杆状病毒将
用于感染昆虫细胞的转瓶,
纯化的env gp的量。 各种纯化的糖蛋白
将比较构建体在各种情况下阻断的能力,
功能测定 在第4-5年,这些绘图研究将扩大
通过使用PCR构建感染性分子克隆,
CAEV和visna的嵌合体。 在env之间切换特定域
这两种病毒的基因将绘制细胞嗜性、抗体
绵羊/山羊的中和、免疫原性和致病性
慢病毒在它们的自然宿主中。 这些生物学特性是
至少部分由Env gp介导,并且在孔之间显著不同。
其特征在于亲本病毒、CAEV和visna病毒。
候选人在应用分子生物学技术方面经验有限。
生物学对疾病发病机理的研究。 主管是一名
慢病毒分子生物学领域公认的专家,
大型活动实验室 候选人已获得独立的
约翰霍普金斯湾景研究院的实验室空间
大学医学院沿着,
比较医学部和大学。 这种组合
的因素应该提供一个良好的环境,完成
建议的研究,并大大提高候选人的发展,
独立研究员。
英文摘要
The human imunodeficiency virus (HIV) is a member of the lentivirus
subfamily, a taxonomic group of nononcogenic retroviruses that
persistently infect cells of the host immune system. These are
enveloped viruses that have a highly glycosylated envelope glycoprotein
(env gp) that stimulates strong immune responses in the infected host.
However, immune responses elicited during natural infection fail to
control virus replication resulting in a persistent infection that
eventually leads to chronic multisystemic disease and death. Many of
the functional domains that mediate cell tropism, cytopathicity, and
neutralization of virus by antibody have been mapped to the env gp of
HIV. However, the properties of the lentivirus envelope that underlie
ineffective anti-lentivirus immune responses are poorly understood and
difficult to evaluate with HIV itself. Insight into these areas are
essential to developing effective immune based strategies against HIV.
Caprine arthritis encephalitis virus (CAEV) of goats and visna virus of
sheep are two closely related, well-characterized lentiviruses that
mirror HIV in many of their biological and structural characteristics.
Infectious molecular clones of both CAEV and visna that have been
completely sequenced are available for study and provide a system in
which to address questions of lentivirus immunogenicity and pathogenesis
in the natural host. This proposal focuses on mapping and
characterizing the functional domains of the ovine/caprine lentivirus
env gp. A set of truncated and mutated env gp genes will be constructed
using the polymerase chain reaction with synthetic oligonucleotides as
primers and the subcloned into a baculovirus expression vector.
Recombinant baculovirus expressing the various forms of the env gp will
be used to infect spinner flasks of insect cells to obtain milligram
quantities of purified env gp. The various purified glycoprotein
constructs will be compared for their ability to block in various
functional assays. In years 4-5 these mapping studies will be extended
by using PCR to construct infectious molecular clones that are envelope
chimeras of CAEV and visna. Switching specific domains between the env
genes of the two viruses will map determinants of cell tropism, antibody
neutralization, immunogenicity and pathogenicity for the ovine/caprine
lentiviruses in their natural host. These biological properties are
mediated at least in part by env gp and differ markedly between the well
characterized parental viruses, CAEV and visna virus.
The candidate has limited experience in applying techniques of molecular
biology to the study of disease pathogenesis. The supervisor is a
recognized expert in the field of lentivirus molecular biology with a
large active lab. The candidate has been provided with independent
laboratory space at the Bayview Research Campus of the Johns Hopkins
University, School of Medicine along with equipment and support from the
Division of Comparative Medicine and the university. This combination
of factors should provide an excellent environment for completing the
proposed studies and greatly enhance the candidate's development as an
independent researcher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and Transgenic Phenotyping Core
-
批准号:7651551
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2009
-
负责人:DAVID L HUSO
-
依托单位:
MENTORING IN MOUSE MOLECULAR PATHOBIOLOGY RESEARCH
-
批准号:6285897
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2001
-
负责人:DAVID L HUSO
-
依托单位:
Mentoring in Mouse Molecular Pathobiology Research
-
批准号:6639835
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2001
-
负责人:DAVID L HUSO
-
依托单位:
Mentoring in Mouse Molecular Pathobiology Research
-
批准号:6895607
-
项目类别:
-
资助金额:$9.07万
-
财政年份:2001
-
负责人:DAVID L HUSO
-
依托单位:
Mentoring in Mouse Molecular Pathobiology Research
-
批准号:6747715
-
项目类别:
-
资助金额:$8.89万
-
财政年份:2001
-
负责人:DAVID L HUSO
-
依托单位:
Mentoring in Mouse Molecular Pathobiology Research
-
批准号:6540556
-
项目类别:
-
资助金额:$8.53万
-
财政年份:2001
-
负责人:DAVID L HUSO
-
依托单位:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
-
批准号:6394248
-
项目类别:
-
资助金额:$18.57万
-
财政年份:1999
-
负责人:DAVID L HUSO
-
依托单位:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
-
批准号:6540175
-
项目类别:
-
资助金额:$19.13万
-
财政年份:1999
-
负责人:DAVID L HUSO
-
依托单位:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
-
批准号:6188328
-
项目类别:
-
资助金额:$18.83万
-
财政年份:1999
-
负责人:DAVID L HUSO
-
依托单位:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
-
批准号:6019902
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1999
-
负责人:DAVID L HUSO
-
依托单位:
NEURONAL DAMAGE RESULTING FROM LENTIVIRAL INFECTION
-
批准号:2655545
-
项目类别:
-
资助金额:$22.5万
-
财政年份:1996
-
负责人:DAVID L HUSO
-
依托单位:
ANIMAL LENTIVIRUSES--STRATEGIES FOR HIV VACCINATION
-
批准号:3069193
-
项目类别:
-
资助金额:$7.86万
-
财政年份:1992
-
负责人:DAVID L HUSO
-
依托单位:
ANIMAL LENTIVIRUSES--STRATEGIES FOR HIV VACCINATION
-
批准号:2281030
-
项目类别:
-
资助金额:$7.86万
-
财政年份:1992
-
负责人:DAVID L HUSO
-
依托单位:
ANIMAL LENTIVIRUSES--STRATEGIES FOR HIV VACCINATION
-
批准号:2281031
-
项目类别:
-
资助金额:$8.61万
-
财政年份:1992
-
负责人:DAVID L HUSO
-
依托单位:
ANIMAL LENTIVIRUSES--STRATEGIES FOR HIV VACCINATION
-
批准号:2039888
-
项目类别:
-
资助金额:$8.54万
-
财政年份:1992
-
负责人:DAVID L HUSO
-
依托单位:
ENVELOPE CARBOHYDRATES OF CAEV--INSIGHT INTO HIV BIOLOGY
-
批准号:3509502
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1991
-
负责人:DAVID L HUSO
-
依托单位:
Cellular and Transgenic Phenotyping Core
-
批准号:8464663
-
项目类别:
-
资助金额:$5.87万
-
财政年份:--
-
负责人:DAVID L HUSO
-
依托单位:
Core C: Murine Models and Biobank
-
批准号:8973861
-
项目类别:
-
资助金额:$19.98万
-
财政年份:--
-
负责人:DAVID L HUSO
-
依托单位:
Cellular and Transgenic Phenotyping Core
-
批准号:8376956
-
项目类别:
-
资助金额:$13.19万
-
财政年份:--
-
负责人:DAVID L HUSO
-
依托单位:
Cellular and Transgenic Phenotyping Core
-
批准号:8242846
-
项目类别:
-
资助金额:$13.35万
-
财政年份:--
-
负责人:DAVID L HUSO
-
依托单位: